Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
G
204840
vs
K
KOSPI 200
Over the past 12 months, GL Pharm Tech Corp has underperformed KOSPI 200, delivering a return of -35% compared to KOSPI 200's +116% growth.
Stocks Performance
204840 vs KOSPI 200
Performance Gap
204840 vs KOSPI 200
Performance By Year
204840 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
GL Pharm Tech Corp
Glance View
GL Pharm Tech Corp is a South Korean pharmaceutical company that develops and sells drug-delivery technologies and finished medicines. Its core business is making medicines easier to take and more reliable by building them in forms such as controlled-release or otherwise modified formulations, rather than selling a wide range of ordinary branded drugs. The company earns money by selling its own pharmaceutical products and by licensing or supplying its formulation technology to other drug makers. Its customers are mainly hospitals, pharmacies, medical distributors, and partner pharmaceutical companies that need specialized dosage forms or manufacturing know-how. What makes its business different is that it sits in the middle of the drug value chain: part product company, part technology supplier. Instead of competing only on the active medicine itself, GL Pharm Tech tries to create value through how a drug is delivered, packaged, and manufactured, which can make existing medicines more useful and harder to copy.